Major Depressive Disorder study: TDCS vs Psychoeducation
Official title Home-Based tDCS for Depression in BPD
ClinicalTrials.gov ID: NCT06972368
What this study is testing
- What it's testing
- This study checks if using a home brain-stimulation device is practical and if it helps lower depression symptoms compared to a fake treatment.
- Who it's for
- People with Borderline Personality Disorder who are currently experiencing moderate to severe depression.
- What's involved
- Participants use a brain-stimulation device at home for 14 sessions over one week. They also complete mental health tests, wear activity trackers, and fill out questionnaires.
- Time commitment
- The study involves one week of daily home treatments and follow-up visits for testing at the end of treatment and six weeks later.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- To be aged between 18 and 65.
- To meet the DSM-IV criteria for BPD.
- To present a moderate depressive episode, defined as a MADRS score ≥ 20 (V1 and V3).
- To be capable to consent to participate in the study.
- To speak either French or English.
You likely can't join if
- \- 1. To have a history of Epilepsy. 2. To have a contraindication for tDCS Medical Devices. 3. To have a history of Cerebrovascular Surgery. 4.
- 7\. To be pregnant. 8. To be currently undergoing neuromodulation treatment. 9. To be currently using benzodiazepines.
See the full eligibility criteria
- To be aged between 18 and 65.
- To meet the DSM-IV criteria for BPD.
- To present a moderate depressive episode, defined as a MADRS score ≥ 20 (V1 and V3).
- To be capable to consent to participate in the study.
- To speak either French or English.
- Participants must have a prescribing doctor or mental health professional responsible
- To maintain a stable psychopharmacological and psychotherapeutic intervention.
- To have access to internet an a smartphone.
- To demonstrate proficiency in independently using a tDCS device.
- To be able to pick up and return the remote tDCS device.
- \- 1. To have a history of Epilepsy. 2. To have a contraindication for tDCS Medical Devices. 3. To have a history of Cerebrovascular Surgery. 4. To present scalp Conditions Affecting tDCS Electrode Placement. 5.
- 7\. To be pregnant. 8. To be currently undergoing neuromodulation treatment. 9. To be currently using benzodiazepines.
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.